Mersana Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
MRSN on Nasdaq
Industry
Pharmaceutical Preparations
Location
840 Memorial Drive, Cambridge, MA

Insiders trading volume in the past year

Mersana Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
EcoR1 Capital, LLC 10%+ Owner $52.5M Jul 27, 2023
David Mott Director $1.62M Jun 11, 2024
Martin H. Huber Jr. President, CEO, Director $1.31M -$88.7K -6.37% Sep 11, 2024
Timothy B. Lowinger SVP, Chief Sci.&Tech. Officer $597K -$55.4K -8.48% Oct 1, 2024
Anna Protopapas Director $535K -$79.7K -13% Jun 11, 2024
Brian DeSchuytner Svp, Coo & Cfo $344K -$52.4K -13.2% Oct 1, 2024
Mohan Bala SVP, Chief Development Officer $274K -$40K -12.7% Oct 25, 2024
Alejandra Carvajal SVP, Chief Legal Officer $260K -$39K -13% Oct 1, 2024
Tushar Misra SVP, Chief Manuf. Officer $162K -$9.1K -5.33% Jan 13, 2024
Arvin Yang SVP, Chief Medical Officer $141K Jan 13, 2023
Ashish Mandelia VP, Chief Accounting Officer $139K -$29.9K -17.7% Oct 1, 2024
Willard H. Dere Director $106K Jun 11, 2024
Michael J. Kaufman Chief Manufacturing Officer $88.4K Jul 15, 2021
Lawrence M. Alleva Director Oct 1, 2024
Kristen Hege Director Jun 11, 2024
Allene M. Diaz Director Jun 11, 2024
Andrew Hack Director Jun 11, 2024

Recent Insider Transactions by Companies or Individuals for Mersana Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.